Depreciation in USD of Autolus Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Autolus Therapeutics plc quarterly/annual Depreciation history and change rate from 2016 to Q3 2025.
  • Autolus Therapeutics plc Depreciation for the quarter ending 30 Sep 2025 was $2.1M, a 10.5% increase year-over-year.
  • Autolus Therapeutics plc Depreciation for the twelve months ending 30 Sep 2025 was $8.2M, a 10.8% increase year-over-year.
  • Autolus Therapeutics plc annual Depreciation for 2024 was $7.6M, a 15.2% increase from 2023.
  • Autolus Therapeutics plc annual Depreciation for 2023 was $6.6M, a 9.59% decline from 2022.
  • Autolus Therapeutics plc annual Depreciation for 2022 was $7.3M, a 15.1% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $8.2M $2.1M +$200K +10.5% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $8M $2.1M +$200K +10.5% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $7.8M $2M +$200K +11.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $7.6M $2M +$200K +11.1% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $7.4M $1.9M +$500K +35.7% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $6.9M $1.9M +$400K +26.7% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $6.5M $1.8M -$100K -5.26% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $6.6M $1.8M 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $1.4M -$400K -22.2% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $1.5M 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $1.9M 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q3 2022 $1.8M 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q1 2021 $6.2M $1.8M +$500K +38.5% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021
Q4 2020 $5.7M $1.7M +$400K +30.8% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023
Q3 2020 $5.3M $1.5M +$400K +36.4% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020
Q2 2020 $4.9M $1.2M +$100K +9.09% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020
Q1 2020 $4.8M $1.3M +$200K +18.2% 01 Jan 2020 31 Mar 2020 6-K 06 May 2021
Q4 2019 $4.6M $1.3M +$655K +102% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022
Q3 2019 $3.95M $1.1M +$800K +267% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020
Q2 2019 $3.15M $1.1M +$600K +120% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020
Q1 2019 $2.55M $1.1M 01 Jan 2019 31 Mar 2019 6-K 07 May 2020
Q4 2018 $645K 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021
Q3 2018 $300K 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019
Q2 2018 $500K 01 Apr 2018 30 Jun 2018 6-K 08 Aug 2019

Autolus Therapeutics plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.6M +$1M +15.2% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 $6.6M -$700K -9.59% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 $7.3M -$1.3M -15.1% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $8.6M +$2.9M +50.9% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 $5.7M +$1.1M +23.9% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 $4.6M +$2.89M +169% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022
2018 $1.71M +$700K +69.4% 01 Oct 2017 30 Sep 2018 20-F 03 Mar 2020
2017 $1.01M +$531K +111% 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020
2016 $478K 01 Oct 2015 30 Sep 2016 20-F 25 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.